On September 8, 2021 NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, reported that Stephen Merrick, President and Chief Executive Officer of NorthStar Medical Radioisotopes, will present at the H.C. Wainwright 23rd Annual Global Investment Conference, being held in a virtual format September 13 – 15, 2021 (Press release, NorthStar Medical Radiostopes, SEP 8, 2021, View Source [SID1234587428]). Additionally, Company management will host one-on-one meetings during the conference.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
A pre-recorded presentation will be available to registered attendees for on-demand viewing beginning Monday, September 13, 2021, at 7:00 a.m. ET on the conference website.
"NorthStar is expanding its leadership position in the rapidly growing area of therapeutic radioisotopes, used in targeted precision radiopharmaceuticals for the treatment of cancer, respiratory and other diseases," said Stephen Merrick, President and Chief Executive Officer of NorthStar Medical Radioisotopes. "In addition, NorthStar continues its successful commercialization of our lead SPECT diagnostic imaging radioisotope, which has informed critical healthcare decisions for hundreds of thousands of patients since launch. Our presentation and meetings will focus on the Company’s robust development portfolio of game-changing therapeutic and diagnostic products, and the ways in which NorthStar is strongly positioned for continued rapid growth and industry leadership. We look forward to sharing our success with the investor community at H.C. Wainwright’s 23rd Annual Global Investment Conference."